Reversal of Dabigatran With Prothrombin Complex Concentrate
Status:
Unknown status
Trial end date:
2016-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate whether Prothrombin Complex Concentrate (PCC) is
effective in reversing the anticoagulant effect of Dabigatran, as assessed by two modified
skin-bleeding tests.